Results 201 to 210 of about 8,702 (224)

Drugs for cataplexy

Annals of Neurology, 1982
C, Thompson, M, Schachter, J D, Parkes
openaire   +2 more sources

Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial

Lancet Neurology, The, 2023
exaly  

Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway

Lancet, The, 2004
Esther Werth, Mehdi Tafti
exaly  

Cataplexy—clinical aspects, pathophysiology and management strategy

Nature Reviews Neurology, 2014
yves Dauvilliers, Regis Lopez
exaly  

Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial

Lancet Neurology, The, 2017
yves Dauvilliers, Philippe Lehert
exaly  

Electroencephalogram in cataplexy

Electroencephalography and Clinical Neurophysiology, 1959
openaire   +2 more sources

Complex movement disorders at disease onset in childhood narcolepsy with cataplexy

Brain, 2011
Giuseppe Plazzi, Fabio Pizza, Christian Franceschini   +2 more
exaly  

Cataplexy

2005
openaire   +1 more source

Clinical, polysomnographic and genome‐wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study

Journal of Sleep Research, 2013
yves Dauvilliers, Sebastiaan Overeem, Rosa Peraita-Adrados   +2 more
exaly  

Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system

Sleep Medicine Reviews, 2005
Seiji Nishino
exaly